XML 41 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Feb. 06, 2017
Apr. 30, 2016
Feb. 29, 2016
Nov. 30, 2015
Aug. 31, 2015
Jun. 30, 2015
Feb. 28, 2017
Feb. 29, 2016
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Mar. 31, 2014
Issuance of common stock                 $ 250,000      
Conversion of stock, shares converted             0.29          
Common stock, par value                 582,599   $ 538,628  
Issuance of common stock, shares   470,000 210,000                  
Change in fair value liability for price adjustable warrants                 $ 103,072    
Debt instruments conversion into shares             6,153,684          
Debt instruments conversion into shares, value             $ 948,000          
Warrants Outstanding                 27,029,995      
Weighted average exercise price                 $ 0.43      
Investment Advisory [Member]                        
Number of common stoc issued for service             300,000          
Fair value of price per share             $ 0.18          
CEO Services [Member] | Restricted Stock [Member]                        
Number of common stoc issued for service             100,000          
Fair value of price per share             $ 0.14          
Stock Purchase Agreement [Member]                        
Notes receivable                 $ 45,000      
Number of amount surrended                 $ 14,049      
Number of warrants surrended                 60,000      
Number of common stock surrended                 87,254      
Stock Purchase Agreement [Member] | Lipo Medics [Member]                        
Sale of stock, shares 862,068                      
Sale of stock transaction 862,068                      
Sale of stock transaction, value $ 250,000                      
Series B Preferred Stock [Member]                        
Preferred stock designated, shares                 1,000      
Series A Preferred Stock [Member]                        
Preferred stock designated, shares                 90,000      
Series C Preferred Stock [Member]                        
Preferred stock designated, shares                       1,200
Common stock, par value         $ 5,000              
Common stock at a conversion price, per share         $ 0.75              
Series C Preferred Stock [Member] | Investor [Member]                        
Conversion of stock, shares converted       90   90            
Common stock at a conversion price, per share       $ 0.31   $ 0.54            
Issuance of common stock, shares       600,000   600,000            
Series D Preferred Stock [Member]                        
Preferred stock designated, shares         220              
Series D Preferred Stock [Member] | Investor [Member]                        
Conversion of stock, shares converted       50       110        
Common stock at a conversion price, per share     $ 0.15 $ 0.28       $ 0.15        
Issuance of common stock, shares       625,000       1,375,000        
Series D Preferred Stock [Member] | Securities Purchase Agreement [Member]                        
Sale of stock, shares         220              
Warrants to purchase, shares         3,440,000              
Common stock exercise price, per share         $ 0.40              
Payments to warrant purchase price         $ 1,100,000              
Issuance of common stock         $ 10,000              
Warrant reduction per share         $ 0.28              
Common stock, par value         $ 5,000              
Common stock at a conversion price, per share         $ 0.40              
Issuance of common stock, shares         2,750,000              
Common stock stated dividend rate         5.00%              
Change in fair value liability for price adjustable warrants         $ 600,000              
Debt beneficial conversion feature         $ 700,000              
Sale of stock transaction         220